H17.01 Adherent leukoma, right eye

Name of the Condition

• Adherent leukoma, right eye

Summary

Adherent leukoma is a condition characterized by a white, scar-like opacity on the cornea that adheres to the underlying tissue. This opacity results from corneal inflammation or injury, leading to fibrous tissue formation. The condition may impair vision depending on the size, location, and density of the opacity. It is often a sequelae of prior corneal damage, such as infection, trauma, or surgery.

Causes

Adherent leukoma typically develops following corneal injury, infection, or inflammation. Common precipitating events include corneal ulcers, herpetic keratitis, chemical burns, or surgical procedures like corneal transplantation. The opacity forms as part of the healing process, where fibrous tissue replaces normal corneal tissue, leading to adhesion and clouding.

Risk Factors

• Prior corneal trauma or surgery
• History of corneal infections (e.g., bacterial, viral)
• Chemical or thermal injury to the eye
• Chronic corneal inflammation or dystrophies
• Prolonged use of contact lenses with poor hygiene
• Systemic conditions affecting corneal health (e.g., autoimmune disorders)

Symptoms

• Blurred or reduced vision
• Visible white opacity on the cornea
• Sensitivity to light (photophobia)
• Eye discomfort or pain
• Difficulty with night vision or glare
• Possible redness or irritation

Diagnosis

Diagnosis involves a comprehensive eye examination, including slit-lamp biomicroscopy to assess the corneal opacity and its adherence to underlying tissue. Visual acuity testing and corneal topography may be performed to evaluate the impact on vision. In some cases, additional tests like corneal pachymetry or anterior segment imaging may be used to assess the opacity’s characteristics and depth.

Treatment Options

Treatment depends on the severity of vision impairment and the opacity’s characteristics. Mild cases may not require intervention, while more significant vision loss may necessitate options like corneal transplantation (penetrating keratoplasty) or phototherapeutic keratectomy (PTK) to remove or reduce the opacity. Management of underlying causes, such as infection or inflammation, is also critical to prevent progression.

Prognosis and Follow-Up

Prognosis varies based on the opacity’s size, location, and impact on vision. Early intervention and proper management of underlying conditions can improve outcomes. Follow-up care typically involves regular eye examinations to monitor for changes in vision or opacity progression. Post-treatment, patients may require ongoing care to address refractive changes or complications.

Complications

Potential complications include permanent vision loss, corneal neovascularization, or increased risk of recurrent infection. In severe cases, the opacity may lead to corneal decompensation or require additional surgical interventions. Chronic irritation or discomfort may also persist if the opacity affects the ocular surface.

Lifestyle & Prevention

Preventive measures include protecting the eyes from trauma or chemical exposure, practicing good contact lens hygiene, and managing underlying conditions like infections or inflammation promptly. Avoiding activities that increase eye injury risk and using protective eyewear can help reduce the likelihood of corneal damage leading to adherent leukoma.

When to Seek Professional Help

Seek medical attention if you experience sudden vision changes, persistent eye pain, increased sensitivity to light, or visible corneal opacity. Prompt evaluation is important to address underlying causes and prevent progression. Regular eye exams are recommended for those with a history of corneal injury or infection.

Tips for Medical Coders

Document the laterality (right eye) clearly in the medical record, as it is required for accurate coding of H17.01. Ensure the diagnosis is supported by clinical findings, such as slit-lamp examination results, and that the opacity’s adherence to the cornea is noted. Avoid coding for unspecified eye when laterality is documented.